Epidemiological profile of common haemoglobinopathies in Arab countries

Journal of Community Genetics

Volumn 4, Issue 2, 2013, Pages 147-167

  Hamamy, Hanan A ^a   Al Allawi, Nasir A S ^b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITY OF DUHOK   (Iraq)

Author keywords

Arab; Haemoglobinopathies; Newborn screening; Premarital screening; Sickle cell disease; Sickle cell trait; Thalassemia

Indexed keywords

ALPHA THALASSEMIA; AMNIOCENTESIS; ARAB; BETA THALASSEMIA; CHORION VILLUS SAMPLING; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; GENETIC SERVICE; HAPLOTYPE; HEMOGLOBINOPATHY; HETEROZYGOSITY; HETEROZYGOTE DETECTION; HUMAN; MANDATORY PROGRAM; NEWBORN SCREENING; PREMARITAL SCREENING; PRENATAL DIAGNOSIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; SICKLE CELL ANEMIA; SICKLE CELL TRAIT;

EID: 84882975529     PISSN: 1868310X     EISSN: 18686001     Source Type: Journal    
DOI: 10.1007/s12687-012-0127-8     Document Type: Review

References (182)

1. Abbes S, Fattoum S, Vidaud M, Goossens M, Rosa J (1991) Sickle cell anemia in the Tunisian population: haplotyping and HB F expression. Hemoglobin 15:1-9
2. Abu-Ghoush MW (2008) Subtypes of alpha thalassemia diagnosed at a Medical Center in Jordan. TAF Prev Med Bull 7(5):373-376
3. Abuzenadah AM, Hussein IM, Damanhouri GA, Sayes FM, Gari MA, Chaudhary AG, Zaher GF, Al-Attas A, Al-Qahtani MH (2011) Molecular basis of beta-thalassemia in the western province of Saudi Arabia: identification of rare beta-thalassemia mutations. Hemoglobin 35:346-357
4. Adekile AD (2001) Sickle cell disease in Kuwait. Hemoglobin 25:219-225
5. Adekile AD, Gu LH, Baysal E, Haider MZ, Al-Fuzae L, Aboobacker KC, Al-Rashied A, Huisman TH (1994) Molecular characterization of alpha-thalassemia determinants, beta-thalassemia alleles, and beta S haplotypes among Kuwaiti Arabs. Acta Haematol 92:176-181
6. Agouti I, Badens C, Abouyoub A, Khattab M, Sayah F, Barakat A, Bennani M (2007) Genotypic correlation between six common beta-thalassemia mutations and the XmnI polymorphism in the Moroccan population. Hemoglobin 31:141-149
7. Agouti I, Badens C, Abouyoub A, Levy N, Bennani M (2008) Molecular basis of beta-thalassemia in Morocco: possible origins of the molecular heterogeneity. Genet Test 12:563-568
8. Al-Aqeel AI (2007) Islamic ethical framework for research into and prevention of genetic diseases. Nat Genet 39:1293-1298
9. Al-Hosani H, Salah M, Osman HM, Farag HM, Anvery SM (2005) Incidence of haemoglobinopathies detected through neonatal screening in the United Arab Emirates. East Mediterr Health J 11:300-307
10. Al-Ali AK, Al-Ateeq S, Imamwerdi BW, Al-Sowayan S, Al-Madan M, Al-Muhanna F, Bashaweri L, Qaw F (2005) Molecular bases of beta-thalassemia in the Eastern Province of Saudi Arabia. J Biomed Biotechnol 322-325
11. Al-Allawi N (2008) The preventive program for hemoglobinopathies in Duhok: an option or a necessity. Duhok Med J 2(1):1-4
12. Al-Allawi N (2011) Molecular characterization of inherited haematological disorders in Iraqis: trying to bridge the gap. HUGO J 5:124
13. Al-Allawi NA, Al-Dousky AA (2010) Frequency of haemoglobinopathies at premarital health screening in Dohuk, Iraq: implications for a regional prevention programme. East Mediterr Health J 16:381-385
14. Al-Allawi NA, Jubrael JM, Hughson M (2006) Molecular characterization of beta-thalassemia in the Dohuk region of Iraq. Hemoglobin 30:479-486
15. Al-Allawi NA, Badi AI, Imanian H, Nikzat N, Jubrael JM, Najmabadi H (2009) Molecular characterization of alpha-thalassemia in the Dohuk region of Iraq. Hemoglobin 33:37-44
16. Al-Allawi NA, Hassan KM, Sheikha AK, Nerweiy FF, Dawood RS, Jubrael J (2010a) Beta-thalassemia mutations among transfusion-dependent thalassemia major patients in Northern Iraq. Mol Biol Int 2010:479282
17. Al-Allawi NA, Shamdeen MY, Rasheed NS (2010b) Homozygosity for the Mediterranean α-thalassemic deletion (hemoglobin Barts hydrops fetalis). Ann Saudi Med 30:153-155
18. Al-Allawi NA, Jalal SD, Nerwey FF, Al-Sayan GO, Al-Zebari SS, Alshingaly AA, Markous RD, Jubrael JM, Hamamy H (2012) Sickle cell disease in the Kurdish population of northern Iraq. Hemoglobin 36:333-342
19. Al-Arrayad S (2006) Genetic diseases in Bahrain. In: Tadmouri GO, Taleb Al-Ali M, Al-Khaja N (eds) Genetic disorders in the Arab World: Bahrain. Centre for Arab Genomic Studies, Dubai
20. Al-Arrayed S (1995) Beta globin gene haplotypes in Bahraini patients with sickle cell anemia. Bahrain Med Bull 17(1):15-20
21. Al-Arrayed S (2005) Campaign to control genetic blood diseases in Bahrain. Community Genet 8:52-55
22. Al-Arrayed (2007) WHO-TIF meeting on the management of Hemoglobin disorders, Nicosia, Cyprus, 16-18 November
23. Al-Arrayed S, Al-Hajeri A (2010) Public awareness of sickle cell disease in Bahrain. Ann Saudi Med 30:284-288
24. Al-Arrayed S, Al-Hajeri A (2012) Newborn screening services in Bahrain between 1985 and 2010. Adv Hematol 2012:903219
25. Al-Arrayed S, Hafadh N, Al-Serasi S (1997) Premarital counselling: an experience from Bahrain. East Med Health J 3:415-419
26. Al-Arrayed S, Hafadh N, Amin S, Al-Mukhareq H, Sanad H (2003) Student screening for inherited blood disorders in Bahrain. East Mediterr Health J 9:344-352
27. Al-Awamy BH (2000) Thalassemia syndromes in Saudi Arabia. Meta-analysis of local studies. Saudi Med J 21:8-17
28. Al-Awamy BH, Al-Muzan M, Al-Turki M, Serjeant GR (1984) Neonatal screening for sickle cell disease in the Eastern Province of Saudi Arabia. Trans R Soc Trop Med Hyg 78:792-794
29. Al-Gazali LI, Alwash R, Abdulrazzaq YM (2005) United Arab Emirates: communities and community genetics. Community Genet 8:186-196
30. Al-Gazali L, Hamamy H, Al-Arrayad S (2006) Genetic disorders in the Arab world. BMJ 333:831-834
31. Alhamdan NA, Almazrou YY, Alswaidi FM, Choudhry AJ (2007) Premarital screening for thalassemia and sickle cell disease in Saudi Arabia. Genet Med 9:372-377
32. Alkindi S, Al-Zadjali S, Al-Madhani A, Daar S, Al-Haddabi H, Al-Abri Q, Gravell D, Berbar T, Pravin S, Pathare A, Krishnamoorthy R (2010) Forecasting hemoglobinopathy burden through neonatal screening in Omani neonates. Hemoglobin 34:135-144
33. Alkindi S, Pathare A, Al-Madhani A, Al-Zadjali S, Al-Haddabi H, Al-Abri Q, Gravell D, Mathew M, Krishnamoorthy R (2011) Neonatal Screening: mean haemoglobin and red cell indices in cord blood from Omani neonates. Sultan Qaboos Univ Med J 11:462-469
34. Alkuraya FS, Kilani RA (2001) Attitude of Saudi families affected with hemoglobinopathies towards prenatal screening and abortion and the influence of religious ruling (Fatwa). Prenat Diagn 21:448-451
35. Almutawa F, Alqamish J (2008) Prevalence of hemoglobinopathies among candidates attending premarital counseling in Bahrain. J Bahrain Med Soc 20(4):145-149
36. Al-Nood H (2009) Thalassemia trait in outpatient clinics of Sana'a City, Yemen. Hemoglobin 33:242-246
37. Al-Nood H, Al-Ismail S, King L, May A (2004) Prevalence of the sickle cell gene in Yemen: a pilot study. Hemoglobin 28:305-315
38. Al-Obaidli A, Hamodat M, Fawzi Z, Abu-Laban M, Gerard N, Krishnamoorthy R (2007) Molecular basis of thalassemia in Qatar. Hemoglobin 31:121-127
39. Al-Qurashi MM, El-Mouzan MI, Al-Herbish AS, Al-Salloum AA, Al-Omar AA (2008) The prevalence of sickle cell disease in Saudi children and adolescents. A community-based survey. Saudi Med J 29:1480-1483
40. Al-Riyami A, Ebrahim GJ (2003) Genetic blood disorders survey in the Sultanate of Oman. J Trop Pediatr 49(Suppl 1):i1-i20
41. Al-Riyami AA, Suleiman AJ, Afifi M, Al-Lamki ZM, Daar S (2001) A community-based study of common hereditary blood disorders in Oman. East Mediterr Health J 7:1004-1011
42. Al-Sulaiman A, Hewison J (2006) Attitudes to prenatal and preimplantation diagnosis in Saudi parents at genetic risk. Prenat Diagn 26:1010-1014
43. Al-Sulaiman A, Saeedi M, Al-Suliman A, Owaidah T (2010a) Postmarital follow-up survey on high risk patients subjected to premarital screening program in Saudi Arabia. Prenat Diagn 30:478-481
44. Al-Sulaiman A, Al-Odaib A, Al-Rejjal R, Hewison J (2010b) Preimplantation genetic diagnosis in Saudi Arabia: parents' experience and attitudes. Prenat Diagn 30:753-757
45. Al-Suliman A (2006) Prevalence of beta-thalassemia trait in premarital screening in Al-Hassa, Saudi Arabia. Ann Saudi Med 26:14-16
46. Al-Sultan A, Phanasgaonkar S, Suliman A, Al-Baqushi M, Nasrullah Z, Al-Ali A (2011) Spectrum of beta-thalassemia mutations in the eastern province of Saudi Arabia. Hemoglobin 35:125-134
47. Alswaidi FM, Memish ZA, O'Brien SJ, Al-Hamdan NA, Al-Enzy FM, Alhayani OA, Al-Wadey AM (2012) At-risk marriages after compulsory premarital testing and counseling for beta-thalassemia and sickle cell disease in Saudi Arabia, 2005-2006. J Genet Couns 21:243-255
48. Alwan A and Modell B (1997) Community control of genetic and congenital disorders. EMRO Technical Publication Series 24: WHO Regional Office for the Eastern Mediterranean Region, Egypt
49. Ayesh SK, Al-Sharef WA, Nassar SM, Thawabteh NA, Abu-Libdeh BY (2005) Prenatal diagnosis of beta-thalassemia in the West Bank and Gaza. Saudi Med J 26:1771-1776
50. Babiker MM, Bashir N, Sarsour N (1999) Prevalence of thalassaemia in schoolchildren in north-eastern Badia, Jordan. East Mediterr Health J 5:1165-1170
51. Badens C, di Martinez MF, Thuret I, Michel G, Mattei JF, Cappellini MD, Lena-Russo D (2000) Molecular basis of haemoglobinopathies and G6PD deficiency in the Comorian population. Hematol J 1:264-268
52. Bashir N, Barkawi M, Sharif L (1991) Prevalence of haemoglobinopathies in school children in Jordan Valley. Ann Trop Paediatr 11:373-376
53. Bashir N, Barkawi M, Sharif L, Momani A, Gharaibeh N (1992) Prevalence of hemoglobinopathies in north Jordan. Trop Geogr Med 44:122-125
54. Baysal E (2001) Hemoglobinopathies in the United Arab Emirates. Hemoglobin 25:247-253
55. Baysal E (2005) Molecular heterogeneity of beta-thalassemia in the United Arab Emirates. Community Genet 8:35-39
56. Baysal E (2011) Molecular basis of beta-thalassemia in the United Arab Emirates. Hemoglobin 35:581-588
57. Baysal E, Indrak K, Bozkurt G, Berkalp A, Aritkan E, Old JM, Ioannou P, Angastiniotis M, Droushiotou A, Yuregir GT (1992) The beta-thalassaemia mutations in the population of Cyprus. Br J Haematol 81:607-609
58. Bennani C, Bouhass R, Perrin-Pecontal P, Tamouza R, Malou M, Elion J, Trabuchet G, Beldjord C, Benabadji M, Labie D (1994) Anthropological approach to the heterogeneity of beta-thalassemia mutations in northern Africa. Hum Biol 66:369-382
59. Bittles A (2012) The global prevalence of consanguinity. Available from http://www.consang.net/
60. Boudrahem-Addour N, Zidani N, Carion N, Labie D, Belhani M, Beldjord C (2009) Molecular heterogeneity of beta-thalassemia in Algeria: how to face up to a major health problem. Hemoglobin 33:24-36
61. Center for Arab Genomic Studies (2012). Available from http://www.cags.org.ae/ctga-search.html
62. Chaabouni H, Chaabouni M, Maazoul F, M'rad R, Jemaa LB, Smaoui N, Terras K, Kammoun H, Belghith N, Ridene H, Oueslati B, Zouari F (2001) Prenatal diagnosis of chromosome disorders in Tunisian population. Ann Genet 44:99-104
63. Charafeddine K, Isma'eel H, Charafeddine M, Inati A, Koussa S, Naja M, Taher A (2008) Survival and complications of beta-thalassemia in Lebanon: a decade's experience of centralized care. Acta Haematol 120:112-116
64. Chouk I, Daoud BB, Mellouli F, Bejaoui M, Gerard N, Dellagi K, Abbes S (2004) Contribution to the description of the beta-thalassemia spectrum in Tunisia and the origin of mutation diversity. Hemoglobin 28:189-195
65. Curuk MA (2007) Hb H (beta4) disease in Cukurova, Southern Turkey. Hemoglobin 31:265-271
66. Daar S, Hussein HM, Merghoub T, Krishnamoorthy R (1998) Spectrum of beta-thalassemia mutations in Oman. Ann N Y Acad Sci 850:404-406
67. Daar S, Hussain HM, Gravell D, Nagel RL, Krishnamoorthy R (2000) Genetic epidemiology of HbS in Oman: multicentric origin for the betaS gene. Am J Hematol 64:39-46
68. Darwish HM, El-Khatib FF, Ayesh S (2005) Spectrum of beta-globin gene mutations among thalassemia patients in the West Bank region of Palestine. Hemoglobin 29:119-132
69. Der Kaloustian VM, Khudr A, Firzli S, Dabbous I (1987) Psychosocial and economic profile of a sample of families with thalassaemic children in Lebanon. J Med Genet 24:772-777
70. Deyde VM, Lo BB, Khalifa IO, Ly B, Ball A, Fattoum S (2002) Epidemiological profile of hemoglobinopathies in the Mauritanian population. Ann Hematol 81:320-321
71. Di RA, Novelletto A, Aliquo MC, Bianco I, Tagarelli A, Brancati C, Colombo B, Felicetti L (1986) Molecular basis for HbH disease in Italy: geographical distribution of deletional and nondeletional alpha-thalassemia haplotypes. Am J Hum Genet 39:631-639
72. Diejomaoh FM, Haider MZ, Dalal H, Abdulaziz A, D'Souza TM, Adekile AD (2000) Influence of alpha-thalassemia trait on the prevalence and severity of anemia in pregnancy among women in Kuwait. Acta Haematol 104:92-94
73. El-Beshlawy A, Youssry I (2009) Prevention of hemoglobinopathies in Egypt. Hemoglobin 33(Suppl 1):S14-S20
74. El-Beshlawy A, Kaddah N, Moustafa A, Mouktar G, Youssry I (2007) Screening for beta-thalassaemia carriers in Egypt: significance of the osmotic fragility test. East Mediterr Health J 13:780-786
75. El-Beshlawy A, El-Shekha A, Momtaz M, Said F, Hamdy M, Osman O, Meshaal S, Gafaar T, Petrou M (2012) Prenatal diagnosis for thalassaemia in Egypt: what changed parents' attitude? Prenat Diagn 32:777-782
76. Elgawhary S, Elbaradie Sahar MY, Rashad WM, Mosaad M, Abdalla MA, Ezzat G, Wali YA, Elbeshlawy A (2008) Prenatal diagnosis of beta-thalassemia in Egypt: implementing accurate high-tech methods did not reflect much on the outcome. Pediatr Hematol Oncol 25:541-548
77. El-Gawhary S, El-Shafie S, Niazi M, Aziz M, El-Beshlawy A (2007) Study of beta-thalassemia mutations using the polymerase chain reaction-amplification refractory mutation system and direct DNA sequencing techniques in a group of Egyptian thalassemia patients. Hemoglobin 31:63-69
78. El-Harth EH, Kuhnau W, Schmidtke J, Stuhrmann M, Nasserallah Z, Al-Shahiri A (1999) Identification and clinical presentation of beta thalassaemia mutations in the eastern region of Saudi Arabia. J Med Genet 36:935-937
79. El-Hazemi MAF, Warsy AS, Bashir N et al (1999) Haplotypes of the â-globin gene as prognostic factors in sickle cell disease. East Mediterr Health J 5(6):1154-1158, Ref Type: Generic
80. El-Hazmi MA (2007) Islamic teachings of bioethics in relation to the practice of medical genetics. Saudi Med J 28:1781-1787
81. El-Hazmi MA, Warsy AS (1994) The frequency of glucose-6-phosphate dehydrogenase phenotypes and sickle cell genes in Al-Qatif oasis. Ann Saudi Med 14:491-494
82. El-Hazmi MA, Warsy AS (1999) Appraisal of sickle-cell and thalassaemia genes in Saudi Arabia. East Mediterr Health J 5:1147-1153
83. El-Hazmi MA, Al-Swailem AR, Warsy AS (1995) Molecular defects in beta-thalassaemias in the population of Saudi Arabia. Hum Hered 45:278-285
84. El-Kalla S, Baysal E (1998a) Alpha-thalassemia in the United Arab Emirates. Acta Haematol 100:49-53
85. El-Kalla S, Baysal E (1998b) Genotype-phenotype correlation of sickle cell disease in the United Arab Emirates. Pediatr Hematol Oncol 15:237-242
86. El-Latif MA, Filon D, Rund D, Oppenheim A, Kanaan M (2002) The beta+-IVS-I-6 (T->C) mutation accounts for half of the thalassemia chromosomes in the Palestinian populations of the mountain regions. Hemoglobin 26:33-40
87. El-Tayeb EN, Yaqoob M, Abdur-Rahim K, Gustavson KH (2008) Prevalence of beta-thalassaemia and sickle cell traits in premarital screening in Al-Qassim, Saudi Arabia. Genet Couns 19:211-218
88. Farra C, Nassar AH, Usta IM, Salameh P, Souaid M, Awwad J (2008) Acceptance of preimplantation genetic diagnosis for beta-thalassemia in Lebanese women with previously affected children. Prenat Diagn 28:828-832
89. Fattoum S (2006) Hemoglobinopathies in Tunisia. An updated review of the epidemiologic and molecular data. Tunis Med 84:687-696
90. Fattoum S, Messaoud T, Bibi A (2004) Molecular basis of beta-thalassemia in the population of Tunisia. Hemoglobin 28:177-187
91. Filon D, Oron V, Krichevski S, Shaag A, Shaag Y, Warren TC, Goldfarb A, Shneor Y, Koren A, Aker M (1994) Diversity of beta-globin mutations in Israeli ethnic groups reflects recent historic events. Am J Hum Genet 54:836-843
92. Filon D, Oron V, Shawa R, Elborno E, Najjar K, Tulchinsky T, Rachmilewitz E, Rund D, Oppenheim A (1995) Spectrum of beta-thalassemia mutations in the Gaza area. Hum Mutat 5:351-353
93. Flint J, Harding RM, Clegg JB, Boyce AJ (1993) Why are some genetic diseases common? Distinguishing selection from other processes by molecular analysis of globin gene variants. Hum Genet 91:91-117
94. Galanello R, Eleftheriou A, Traeger-Synedinos J, Old J, Petrou M, Angastiniotis M (2003) Prevention of thalassaemia and other haemoglobin disorders, vol. 1. Thalassaemia International Federation Publications, Nicosia
95. Ganeshaguru K, Acquaye JK, Samuel AP, Hassounah F, Agyeiobese S, Azrai LM, Sejeny SA, Omer A (1987) Prevalence of thalassaemias in ethnic Saudi Arabians. Trop Geogr Med 39:238-243
96. Gupta A, Hattori Y, Gupta UR, Sarwai S, Nigam N, Singhal P, Agarwal S (2003) Molecular genetic testing of beta-thalassemia patients of Indian origin and a novel 8-bp deletion mutation at codons 36/37/38/39. Genet Test 7:163-168
97. Hadavi V, Taromchi AH, Malekpour M, Gholami B, Law HY, Almadani N, Afroozan F, Sahebjam F, Pajouh P, Kariminejad R, Kariminejad MH, Azarkeivan A, Jafroodi M, Tamaddoni A, Puehringer H, Oberkanins C, Najmabadi H (2007) Elucidating the spectrum of alpha-thalassemia mutations in Iran. Haematologica 92:992-993
98. Haider M, Adekile A (2005) Alpha-2-globin gene polyadenylation (AATAAA->AATAAG) mutation in hemoglobin H disease among Kuwaitis. Med Princ Pract 14(Suppl 1):73-76
99. Haj Khelil A, Denden S, Leban N, Daimi H, Lakhdhar R, Lefranc G, Ben CJ, Perrin P (2010) Hemoglobinopathies in North Africa: a review. Hemoglobin 34:1-23
100. Hajer S, Neila T, Sondess HF, Fekria O, Nabila A, Mahbouba K, Melika D, Faida O, Amina B, Raja B, Hedi R, Sadok M, Naima K, Slaheddine F, Taieb M (2012) A lower-cost protocol for sickle cell disease neonatal screening in Tunisia. Ann Saudi Med 32:49-52
101. Hamamy H and Al-Hait S (2007) Premarital Screening program for beta-thalassemia in Jordan. Available from http://ambassadors.net/archives/ issue21/selectedstudy.htm
102. Hamamy H, Alwan A (1994) Hereditary disorders in the Eastern Mediterranean Region. Bull World Health Organ 72:145-154
103. Hamamy H, Bittles AH (2008) Genetic clinics in Arab communities: meeting individual, family and community needs. Public Health Genom 12:30-40
104. Hamamy H, Al-Hait S, Alwan A, Ajlouni K (2007) Jordan: communities and community genetics. Community Genet 10:52-60
105. Harteveld CL, Higgs DR (2010) Alpha-thalassaemia. Orphanet J Rare Dis 5:13
106. Hassan MK, Taha JY, Al-Naama LM, Widad NM, Jasim SN (2003) Frequency of haemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in Basra. East Mediterr Health J 9:45-54
107. Hassan SM, Hamza N, Jaffer Al-Lawatiya F, Jaffer MA, Harteveld CL, Rajab A, Giordano PC (2010) Extended molecular spectrum of beta- and alpha-thalassemia in Oman. Hemoglobin 34:127-134
108. Hellani A, Fadel E, El-Sadadi S, El-Sweilam H, El-Dawood A, Abu-Amero KK (2009) Molecular spectrum of alpha-thalassemia mutations in microcytic hypochromic anemia patients from Saudi Arabia. Genet Test Mol Biomarkers 13:219-221
109. Henderson S, Timbs A, McCarthy J, Gallienne A, Van MM, Masters G, May A, Khalil MS, Schuh A, Old J (2009) Incidence of haemoglobinopathies in various populations - the impact of immigration. Clin Biochem 42:1745-1756
110. Higgs DR, Goodbourn SE, Lamb J, Clegg JB, Weatherall DJ, Proudfoot NJ (1983) Alpha-thalassaemia caused by a polyadenylation signal mutation. Nature 306:398-400
111. Hussein IR, Temtamy SA, El-Beshlawy A, Fearon C, Shalaby Z, Vassilopoulos G, Kazazian HH Jr (1993) Molecular characterization of beta-thalassemia in Egyptians. Hum Mutat 2:48-52
112. Hussein G, Fawzy M, Serafi TE, Ismail EF, Metwally DE, Saber MA, Giansily M, Schved JF, Pissard S, Martinez PA (2007) Rapid detection of beta-thalassemia alleles in Egypt using naturally or amplified created restriction sites and direct sequencing: a step in disease control. Hemoglobin 31:49-62
113. Inati A, Taher A, Bou AW, Koussa S, Kaspar H, Shbaklo H, Zalloua PA (2003) Beta-globin gene cluster haplotypes and HbF levels are not the only modulators of sickle cell disease in Lebanon. Eur J Haematol 70:79-83
114. Jain RC (1979) Haemoglobinopathies in Libya. J Trop Med Hyg 82(6):128-132
115. Jain RC (1985) Sickle cell and thalassaemic genes in Libya. Trans R Soc Trop Med Hyg 79:132-133
116. Jalal SD, Al-Alawi NA, Faraj AH, Ahmed NH (2008) Prevalence of hemoglobinopathies in Sulaimani-Iraq. Dohuk Med J 2(1):71-79, Dohuk Med J 2[1]
117. Jalal SD, Al-Allawi NA, Bayat N, Imanian H, Najmabadi H, Faraj A (2010) Beta-thalassemia mutations in the Kurdish population of northeastern Iraq. Hemoglobin 34:469-476
118. Jassim N, Merghoub T, Pascaud O, al MH, Ducrocq R, Labie D, Elion J, Krishnamoorthy R, Arrayed SA (1998) Molecular basis of beta-thalassemia in Bahrain: an epicenter for a Middle East specific mutation. Ann N Y Acad Sci 850:407-409
119. Jassim N, Al-Arrayed S, Gerard N, Al-Mukharraq H, Al-Ajami A, Ducrocoq R et al (2001) Molecular basis of á-thalassemia in Bahrain. Bahrain Med Bull 23(1):3-7
120. Jiffri EH, Bogari N, Zidan KH, Teama S, Elhawary NA (2010) Molecular updating of beta-thalassemia mutations in the Upper Egyptian population. Hemoglobin 34:538-547
121. Kanavakis E, Papassotiriou I, Karagiorga M, Vrettou C, Metaxotou-Mavrommati A, Stamoulakatou A, Kattamis C, Traeger-Synodinos J (2000) Phenotypic and molecular diversity of haemoglobin H disease: a Greek experience. Br J Haematol 111:915-923
122. Kattamis C, Hu H, Cheng G, Reese AL, Gonzalez-Redondo JM, Kutlar A, Kutlar F, Huisman TH (1990) Molecular characterization of beta-thalassaemia in 174 Greek patients with thalassaemia major. Br J Haematol 74:342-346
123. Kulozik AE, Wainscoat JS, Serjeant GR, Kar BC, Al-Awamy B, Essan GJ, Falusi AG, Haque SK, Hilali AM, Kate S (1986) Geographical survey of beta S-globin gene haplotypes: evidence for an independent Asian origin of the sickle-cell mutation. Am J Hum Genet 39:239-244
124. Kyriacou K, Al-Quobaili F, Pavlou E, Christopoulos G, Ioannou P, Kleanthous M (2000) Molecular characterization of beta-thalassemia in Syria. Hemoglobin 24:1-13
125. Labie D, Bennani C, Beldjord C (1990) Beta-thalassemia in Algeria. Ann N Y Acad Sci 612:43-54
126. Lal A, Vichinsky EP (2011) Sickle cell disease. In: Hoffbrand AV, Catovsky D, Tuddenham EGD, Green AR (eds) Postgraduate haematology, 6th edn. Wiley-Blackwell, Chichester, pp 109-125
127. Laradi S, Haj KA, Omri H, Chaieb A, Mahjoub T, Benlimam H, Amri F, Saad A, Miled A, Leturcq F, Ben CJ, Beldjord C (2000) Molecular analysis and prenatal diagnosis of beta-thalassemia: about our experience in central Tunisia. Ann Biol Clin (Paris) 58:453-460
128. Lemsaddek W, Picanco I, Seuanes F, Nogueira P, Mahmal L, Benchekroun S, Khattab M, Osorio-Almeida L (2004) The beta-thalassemia mutation/haplotype distribution in the Moroccan population. Hemoglobin 28:25-37
129. Makhoul NJ, Wells RS, Kaspar H, Shbaklo H, Taher A, Chakar N, Zalloua PA (2005) Genetic heterogeneity of Beta thalassemia in Lebanon reflects historic and recent population migration. Ann Hum Genet 69:55-66
130. Memish ZA, Saeedi MY (2011) Six-year outcome of the national premarital screening and genetic counseling program for sickle cell disease and beta-thalassemia in Saudi Arabia. Ann Saudi Med 31:229-235
131. Mesbah-Amroun H, Rouabhi F, Ducrocq R, Elion J (2008) Molecular basis of alpha-thalassemia in Algeria. Hemoglobin 32:273-278
132. Mohammed AM, Al-Hilli F, Nadkarni KV, Bhagwat GP, Bapat JP (1992) Hemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in hospital births in Bahrain. Ann Saudi Med 12:536-539
133. Mseddi S, Gargouri J, Labiadh Z, Kassis M, Elloumi M, Ghali L, Dammak J, Harrabi M, Souissi T, Frikha M (1999) Prevalence of hemoglobin abnormalities in Kebili (Tunisian South). Rev Epidemiol Sante Publique 47:29-36
134. Nafei A (1992) Prevalence of hemogolobinopathies and study of their genetics. Tanta Med J 20(1):467-480
135. Najmabadi H, Karimi-Nejad R, Sahebjam S, Pourfarzad F, Teimourian S, Sahebjam F, Amirizadeh N, Karimi-Nejad MH (2001) The beta-thalassemia mutation spectrum in the Iranian population. Hemoglobin 25:285-296
136. Nasserullah Z, Al-Jame A, AbuSrair H, Al-Qatari G, Al-Naim S, Al-Aqib A, Mokhtar M (1998) Neonatal screening for sickle cell disease, glucose-6-phosphate dehydrogenase deficiency and a-thalassemia in Qatif and Al Hasa. Ann Saudi Med 18:289-292
137. Nasserullah Z, Alshammari A, Abbas MA, Abu-Khamseen Y, Qadri M, Jafer SA, Wabel MA (2003) Regional experience with newborn screening for sickle cell disease, other hemoglobinopathies and G6PD deficiency. Ann Saudi Med 23:354-357
138. Ogedegbe HO (2007) β-globin gene cluster haplotype analysis as a predictor of sickle cell disease severity. Labmedicine 38(9):563-568
139. Orkin SH, Goff SC, Hechtman RL (1981) Mutation in an intervening sequence splice junction in man. Proc Natl Acad Sci U S A 78:5041-5045
140. Oron-Karni V, Filon D, Shifrin Y, Fried E, Pogrebijsky G, Oppenheim A, Rund D (2000) Diversity of alpha-globin mutations and clinical presentation of alpha-thalassemia in Israel. Am J Hematol 65:196-203
141. Pagnier J, Mears JG, Dunda-Belkhodja O, Schaefer-Rego KE, Beldjord C, Nagel RL, Labie D (1984) Evidence for the multicentric origin of the sickle cell hemoglobin gene in Africa. Proc Natl Acad Sci U S A 81:1771-1773
142. Perrin P, Bouhassa R, Mselli L, Garguier N, Nigon VM, Bennani C, Labie D, Trabuchet G (1998) Diversity of sequence haplotypes associated with beta-thalassaemia mutations in Algeria: implications for their origin. Gene 213:169-177
143. Pirastu M, Galanello R, Doherty MA, Tuveri T, Cao A, Kan YW (1987) The same beta-globin gene mutation is present on nine different beta-thalassemia chromosomes in a Sardinian population. Proc Natl Acad Sci U S A 84:2882-2885
144. PubMed (2012) http://www.ncbi.nlm.nih.gov/PubMed
145. Quadri MI, Islam SI, Nasserullah Z (2000) The effect of alpha-thalassemia on cord blood red cell indices and interaction with sickle cell gene. Ann Saudi Med 20:367-370
146. Rahgozar S, Poorfathollah AA, Moafi AR, Old JM (2000) Beta S gene in Central Iran is in linkage disequilibrium with the Indian-Arab haplotype. Am J Hematol 65:192-195
147. Rahimi Z, Karimi M, Haghshenass M, Merat A (2003) Beta-globin gene cluster haplotypes in sickle cell patients from southwest Iran. Am J Hematol 74:156-160
148. Rajab A and Jaffar MA (2008) Genetic diseases in the Sultanate of Oman: public health perspective. Genetic disorders in Arab populations: a 2008 update. In: Tadmouri GO, Taleb Al-Ali M, Al-Khaja N (eds) Genetic disorders in the Arab World: Oman. Centre for Arab Genomic Studies, Dubai
149. Rajab AG, Patton MA, Modell B (2000) Study of hemoglobinopathies in Oman through a national register. Saudi Med J 21:1168-1172
150. Rajab KE, Issa AA, Mohammed AM, Ajami AA (2006) Sickle cell disease and pregnancy in Bahrain. Int J Gynaecol Obstet 93:171-175
151. Rizk S, Zayed S, Aziz M (2005) Identification of five common Alpha-thalassaemia genotypes among a group of Egyptian neonates by single tube PCR. Med J Cairo Univ 73(3):483-488
152. Rosatelli MC, Tuveri T, Scalas MT, Leoni GB, Sardu R, Faa V, Meloni A, Pischedda MA, Demurtas M, Monni G (1992) Molecular screening and fetal diagnosis of beta-thalassemia in the Italian population. Hum Genet 89:585-589
153. Rouabhi F, Lapoumeroulie C, Amselem S, Krishnamoorthy R, Adjrad L, Girot R, Chardin P, Benabdji M, Labie D, Beldjord C (1988) DNA haplotype distribution in Algerian beta thalassaemia patients. An extended evaluation by family studies and representative molecular characterization. Hum Genet 79:373-376
154. Sadiq MF, Eigel A, Horst J (2001) Spectrum of beta-thalassemia in Jordan: identification of two novel mutations. Am J Hematol 68:16-22
155. Samarah F, Ayesh S, Athanasiou M, Christakis J, Vavatsi N (2009) Beta(S)-globin gene cluster haplotypes in the West Bank of Palestine. Hemoglobin 33:143-149
156. Samavat A, Modell B (2004) Iranian national thalassaemia screening programme. BMJ 329:1134-1137
157. Serjeant GR (1989) Geography and the clinical picture of sickle cell disease. An overview. Ann N Y Acad Sci 565:109-119
158. Siala H, Ouali F, Messaoud T, Bibi A, Fattoum S (2008) alpha-Thalassaemia in Tunisia: some epidemiological and molecular data. J Genet 87:229-234
159. Simsek M, Nassar K, Baner A (1993) Incidence and genotype distribution of alpha-thalassemias in Kuwait. Med Princ Pract 3(4):181-184
160. Sirdah M, Bilto YY, El-Jabour S, Najjar K (1998) Screening secondary school students in the Gaza strip for beta-thalassaemia trait. Clin Lab Haematol 20:279-283
161. Sunna EI, Gharaibeh NS, Knapp DD, Bashir NA (1996) Prevalence of hemoglobin S and beta-thalassemia in northern Jordan. J Obstet Gynaecol Res 22:17-20
162. Tadmouri GO, Gulen RI (2003) Deniz: the electronic database for beta-thalassemia mutations in the Arab world. Saudi Med J 24:1192-1198
163. Tadmouri GO, Garguier N, Demont J, Perrin P, Basak AN (2001) History and origin of beta-thalassemia in Turkey: sequence haplotype diversity of beta-globin genes. Hum Biol 73:661-674
164. Talafih K, Hunaiti AA, Gharaibeh N, Gharaibeh M, Jaradat S (1996) The prevalence of hemoglobin S and glucose-6-phosphate dehydrogenase deficiency in Jordanian newborn. J Obstet Gynaecol Res 22:417-420
165. Tarazi I, Al-Najjar E, Lulu N, Sirdah M (2007) Obligatory premarital tests for beta-thalassaemia in the Gaza Strip: evaluation and recommendations. Int J Lab Hematol 29:111-118
166. Teebi A, Farag T (1997a) Teebi A (2010) Genetic disorders among Arab populations, 2nd edn. Springer, New York
167. Teebi A, Farag T (1997b) Genetic disorders among Arab populations. Oxford monographs on medical genetics No. 30. Oxford University Press, New York
168. Teebi AS, Teebi SA (2005) Genetic diversity among the Arabs. Community Genet 8:21-26
169. Tremblay C, Hamilton B, Sala M, Paoloni J, Chalabi H (2011) Prevalence of haemoglobinopathy in sportsmen in Qatar. Br J Sports Med 45:317
170. UNDP (2012) Arab Human Development Reports (AHDR) - United Nations Development Programme. Available from http://www.arab-hdr.org/undpcos.aspx
171. Weatherall DJ, Clegg JB (2001) Thalassemia syndromes, 4th edn. Blackwell, Oxford
172. White JM, Byrne M, Richards R, Buchanan T, Katsoulis E, Weerasingh K (1986) Red cell genetic abnormalities in Peninsular Arabs: sickle haemoglobin, G6PD deficiency, and alpha and beta thalassaemia. J Med Genet 23:245-251
173. White JM, Christie BS, Nam D, Daar S, Higgs DR (1993) Frequency and clinical significance of erythrocyte genetic abnormalities in Omanis. J Med Genet 30:396-400
174. WHO (2006) Medical genetic services in developing countries: the ethical, legal and social implications of genetic testing and screening. WHO, Geneva
175. WHO (2012) http://www.emro.who.int/HIS/VHSL/
176. World Bank (2012) http://data.worldbank.org/indicator/NY.GNP.PCAP.CD
177. World Health Organization (2010) http://rho.emro.who.int/rhodata/ InstantAtlasMaps/AllIndicators/atlas.html
178. Yahya H, Khalel K, Al-Allawi N, Helmi F (1996) Thalassaemia genes in Baghdad, Iraq. East Mediterr Health J 2:315-319
179. Yavarian M, Karimi M, Zorai A, Harteveld CL, Giordano PC (2005) Molecular basis of Hb H disease in southwest Iran. Hemoglobin 29:43-50
180. Zahed L, Bou-Dames J (1997) Acceptance of first-trimester prenatal diagnosis for the haemoglobinopathies in Lebanon. Prenat Diagn 17:423-428
181. Zahed L, Demont J, Bouhass R, Trabuchet G, Hanni C, Zalloua P, Perrin P (2002) Origin and history of the IVS-I-110 and codon 39 beta-thalassemia mutations in the Lebanese population. Hum Biol 74:837-847
182. Zorai A, Harteveld CL, Bakir A, Van DP, Falfoul A, Dellagi K, Abbes S, Giordano PC (2002) Molecular spectrum of alpha-thalassemia in Tunisia: epidemiology and detection at birth. Hemoglobin 26:353-362